Explore our tests
Discover the right genetic test for your patient in our complete list of tests and panels.
Showing 10 out of 407 tests
Low Levels of Free Carnitine (C0) via the SLC22A5 Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 16039
2 - 3 weeks (7 - 16 days STAT)•Test 160391 Gene
Lymphedema Panel
NGS with CNV (Exome or Genome Platform)2 - 3 weeks (6 - 12 days STAT)•Test 10303
2 - 3 weeks (6 - 12 days STAT)•Test 1030314 Genes
Lynch Syndrome/Constitutional Mismatch Repair Deficiency Panel
NGS with CNV (PGselect Platform)2 - 3 weeks (7 - 16 days STAT)•Test 5463
2 - 3 weeks (7 - 16 days STAT)•Test 54635 Genes
Lynch Syndrome via MLPA of PMS2
Multiplex Ligation-Dependent Probe Amplification Assay2 - 3 weeks (6 - 11 days STAT)•Test 6062
2 - 3 weeks (6 - 11 days STAT)•Test 60621 Gene
Lynch Syndrome via the MSH2 Exons 1-7 Inversion
Targeted PCR2 - 3 weeks (8 - 10 days STAT)•Test 906
2 - 3 weeks (8 - 10 days STAT)•Test 9061 Gene
Lysosomal Storage Disorders Panel
NGS with CNV (Exome or Genome Platform)2 - 3 weeks (6 - 12 days STAT)•Test 13065
2 - 3 weeks (6 - 12 days STAT)•Test 13065146 Genes
Machado-Joseph Disease (MJD)/Spinocerebellar Ataxia Type 3 (SCA3) via the ATXN3 CAG Repeat Expansion
Repeat-Primed PCR & Fragment Length1 - 2 weeks (6 - 10 days STAT)•Test 13213
1 - 2 weeks (6 - 10 days STAT)•Test 132131 Gene
Male Infertility Panel
NGS with CNV (Exome or Genome Platform)2 - 3 weeks (6 - 12 days STAT)•Test 4511
2 - 3 weeks (6 - 12 days STAT)•Test 4511137 Genes
Malignant Hyperthermia Susceptibility Panel
NGS with CNV (Exome or Genome Platform)2 - 3 weeks (7 - 16 days STAT)•Test 10059
2 - 3 weeks (7 - 16 days STAT)•Test 100593 Genes
Manitoba Oculotrichoanal Syndrome (MOTA) via the FREM1 Exon 8-23 Deletion
Targeted PCR2 - 3 weeks (8 - 10 days STAT)•Test 3782
2 - 3 weeks (8 - 10 days STAT)•Test 37821 Gene